{"disease":{"id":"esophagus-cancer-adenocarcinoma","name":"esophagus cancer adenocarcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04151524","title":"Classification of Adenocarcinoma of the Esophagogastric Junction","phase":"","overall_status":"UNKNOWN","enrollment_count":1658,"lead_sponsor_name":"St. James's Hospital, Ireland","has_results":false},{"nct_id":"NCT03896958","title":"The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"SpeciCare","has_results":false},{"nct_id":"NCT06381583","title":"A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma","phase":"","overall_status":"COMPLETED","enrollment_count":658,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT04669951","title":"Urokinase-type Plasminogen Activator Receptor and Gastroesophageal Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Michael Patrick Achiam","has_results":false},{"nct_id":"NCT02971956","title":"Pembrolizumab in Refractory Advanced Esophageal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":true},{"nct_id":"NCT04161781","title":"A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT05069766","title":"Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT02344810","title":"C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Eastern Cooperative Oncology Group","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}